Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

MYC chromosomal aberration in differential diagnosis between Burkitt and other aggressive lymphomas.

Aquino G, Marra L, Cantile M, De Chiara A, Liguori G, Curcio MP, Sabatino R, Pannone G, Pinto A, Botti G, Franco R.

Infect Agent Cancer. 2013 Sep 30;8(1):37. doi: 10.1186/1750-9378-8-37.

2.

Patterns of genomic aberrations suggest that Burkitt lymphomas with complex karyotype are distinct from other aggressive B-cell lymphomas with MYC rearrangement.

Havelange V, Ameye G, Théate I, Callet-Bauchu E, Mugneret F, Michaux L, Dastugue N, Penther D, Barin C, Collonge-Rame MA, Baranger L, Terré C, Nadal N, Lippert E, Laï JL, Cabrol C, Tigaud I, Herens C, Hagemeijer A, Raphael M, Libouton JM, Poirel HA; GFCH (Groupe Francophone de Cytogénétique Hématologique).

Genes Chromosomes Cancer. 2013 Jan;52(1):81-92. doi: 10.1002/gcc.22008. Epub 2012 Sep 25.

PMID:
23012230
3.

B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.

Snuderl M, Kolman OK, Chen YB, Hsu JJ, Ackerman AM, Dal Cin P, Ferry JA, Harris NL, Hasserjian RP, Zukerberg LR, Abramson JS, Hochberg EP, Lee H, Lee AI, Toomey CE, Sohani AR.

Am J Surg Pathol. 2010 Mar;34(3):327-40. doi: 10.1097/PAS.0b013e3181cd3aeb.

4.

Commentary on the WHO classification of tumors of lymphoid tissues (2008): "Gray zone" lymphomas overlapping with Burkitt lymphoma or classical Hodgkin lymphoma.

Hasserjian RP, Ott G, Elenitoba-Johnson KS, Balague-Ponz O, de Jong D, de Leval L.

J Hematop. 2009 Jul;2(2):89-95. doi: 10.1007/s12308-009-0039-7. Epub 2009 Jun 27.

5.

Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge.

Boerma EG, Siebert R, Kluin PM, Baudis M.

Leukemia. 2009 Feb;23(2):225-34. doi: 10.1038/leu.2008.281. Epub 2008 Oct 16. Review.

PMID:
18923440
6.

A new diagnostic algorithm for Burkitt and diffuse large B-cell lymphomas based on the expression of CSE1L and STAT3 and on MYC rearrangement predicts outcome.

Soldini D, Montagna C, Schüffler P, Martin V, Georgis A, Thiesler T, Curioni-Fontecedro A, Went P, Bosshard G, Dehler S, Mazzuchelli L, Tinguely M.

Ann Oncol. 2013 Jan;24(1):193-201. doi: 10.1093/annonc/mds209. Epub 2012 Sep 11.

7.

[Molecular genetic features of sporadic Burkitt's lymphoma in children].

Yang WP, Huang H, Gong LP, Wu Y, Xu HY, Zou Y, Lü BB, Zhong HS, Deng QQ, Xiao Q, Zeng ST, Zhu CD.

Zhonghua Bing Li Xue Za Zhi. 2010 Dec;39(12):819-24. Chinese.

PMID:
21215097
8.

Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas.

Pillai RK, Sathanoori M, Van Oss SB, Swerdlow SH.

Am J Surg Pathol. 2013 Mar;37(3):323-32. doi: 10.1097/PAS.0b013e31826cebad.

PMID:
23348205
9.

A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.

Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, Barth TF, Bernd HW, Cogliatti SB, Dierlamm J, Feller AC, Hansmann ML, Haralambieva E, Harder L, Hasenclever D, Kühn M, Lenze D, Lichter P, Martin-Subero JI, Möller P, Müller-Hermelink HK, Ott G, Parwaresch RM, Pott C, Rosenwald A, Rosolowski M, Schwaenen C, Stürzenhofecker B, Szczepanowski M, Trautmann H, Wacker HH, Spang R, Loeffler M, Trümper L, Stein H, Siebert R; Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe.

N Engl J Med. 2006 Jun 8;354(23):2419-30.

10.

Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina.

Bürgesser MV, Gualco G, Diller A, Natkunam Y, Bacchi CE.

Ann Diagn Pathol. 2013 Jun;17(3):250-5. doi: 10.1016/j.anndiagpath.2012.11.001. Epub 2012 Dec 14.

PMID:
23246412
11.

Molecular classification of MYC-driven B-cell lymphomas by targeted gene expression profiling of fixed biopsy specimens.

Carey CD, Gusenleitner D, Chapuy B, Kovach AE, Kluk MJ, Sun HH, Crossland RE, Bacon CM, Rand V, Dal Cin P, Le LP, Neuberg D, Sohani AR, Shipp MA, Monti S, Rodig SJ.

J Mol Diagn. 2015 Jan;17(1):19-30. doi: 10.1016/j.jmoldx.2014.08.006. Epub 2014 Nov 7.

12.

Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach.

Bellan C, Stefano L, Giulia de F, Rogena EA, Lorenzo L.

Hematol Oncol. 2009 Dec;27(4):182-5. doi: 10.1002/hon.914. Review.

PMID:
19670467
13.

The gray zone between Burkitt's lymphoma and diffuse large B-cell lymphoma from a genetics perspective.

Salaverria I, Siebert R.

J Clin Oncol. 2011 May 10;29(14):1835-43. doi: 10.1200/JCO.2010.32.8385. Epub 2011 Apr 11. Review.

PMID:
21482997
14.

Diagnosis of 'double hit' diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC.

Swerdlow SH.

Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):90-9. doi: 10.1182/asheducation-2014.1.90. Epub 2014 Nov 18. Review.

PMID:
25696840
15.

Double-hit B-cell lymphomas.

Aukema SM, Siebert R, Schuuring E, van Imhoff GW, Kluin-Nelemans HC, Boerma EJ, Kluin PM.

Blood. 2011 Feb 24;117(8):2319-31. doi: 10.1182/blood-2010-09-297879. Epub 2010 Nov 30. Review.

16.

Non-Hodgkin's lymphoma: the old and the new.

Cabanillas F.

Clin Lymphoma Myeloma Leuk. 2011 Jun;11 Suppl 1:S87-90. doi: 10.1016/j.clml.2011.03.029. Epub 2011 Apr 28. Review.

PMID:
22035756
17.

Aggressive B-cell lymphomas: frequency, immunophenotype, and genetics in a reference laboratory population.

Naeini YB, Wu A, O'Malley DP.

Ann Diagn Pathol. 2016 Dec;25:7-14. doi: 10.1016/j.anndiagpath.2016.07.008. Epub 2016 Aug 17.

PMID:
27806850
18.

The impact of MYC expression in lymphoma biology: beyond Burkitt lymphoma.

Smith SM, Anastasi J, Cohen KS, Godley LA.

Blood Cells Mol Dis. 2010 Dec 15;45(4):317-23. doi: 10.1016/j.bcmd.2010.08.002. Epub 2010 Sep 6. Review.

PMID:
20817505
19.

Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach.

Bellan C, Stefano L, Giulia de F, Rogena EA, Lorenzo L.

Hematol Oncol. 2010 Jun;28(2):53-6. doi: 10.1002/hon.916. Review.

PMID:
19844983
20.

Application of interphase fluorescence in situ Hybridization for the detection of the Burkitt translocation t(8;14)(q24;q32) in B-cell lymphomas.

Siebert R, Matthiesen P, Harder S, Zhang Y, Borowski A, Zühlke-Jenisch R, Metzke S, Joos S, Weber-Matthiesen K, Grote W, Schlegelberger B.

Blood. 1998 Feb 1;91(3):984-90.

Supplemental Content

Support Center